Abstract

BackgroundIt has been reported that the determination of magnesium levels could be used as a surrogate marker of efficacy in chemotherapy regimens with cetuximab.Purpose To investigate the hypomagnesemia caused by...

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
ESMO Clinical Practice Guideline update on the use of immunotherapy in early stage and advanced renal cell carcinoma
T Powles ... G De Velasco
Annals of Oncology | VOL. 32
T Powles, et. al.T Powles ... G De Velasco
28 Sep 2021
Efficacy and clinical outcome of chemotherapy and endocrine therapy as first-line treatment in patients with hormone receptor-positive HER2-negative metastatic breast cancer.
Yang Yuan ... Li Bian
Chinese medical journal | VOL. 136
Yang Yuan, et. al.Yang Yuan ... Li Bian
27 Apr 2023
Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis.
N Haj Mohammad ... H W M Van Laarhoven
Cancer and Metastasis Reviews | VOL. 34
N Haj Mohammad, et. al.N Haj Mohammad ... H W M Van Laarhoven
13 Aug 2015
Abstract PO1-04-12: Palbociclib versus ribociclib in first-line treatment of patients with hormone-receptor positive HER2 negative advanced breast cancer – real world outcome data from the German registry platform OPAL
Marc Thill ... Mark-Oliver Zahn
Cancer Research | VOL. 84
Marc Thill, et. al.Marc Thill ... Mark-Oliver Zahn
02 May 2024
View more papers

More From: European Journal of Hospital Pharmacy: Science and Practice

Paper Title
Journal
Date
Author
EAHP and GS1 publish report of UZ Leuven meeting on bedside scanning and medicines bar coding
Richard Price
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Richard PriceRichard Price
19 May 2014
In peer review we trust—or do we?
Phil Wiffen
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil WiffenPhil Wiffen
19 May 2014
European Parliament Committee approves €3 billion public-private partnership with industry on new medicine development
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
19 May 2014
Chapter 5: Appraising the evidence
Phil Wiffen ... Hao Lu
European Journal of Hospital Pharmacy: Science and Practice | VOL. 21
Phil Wiffen, et. al.Phil Wiffen ... Hao Lu
19 May 2014
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.